Guerbet: targets raised for 2024

(CercleFinance.com) - Guerbet has raised its targets for 2024, now expecting sales growth in excess of 9% on a like-for-like and CER basis, and a return of the restated EBITDA margin to a level above that of 2021 (14.
4%).

In the first half of 2024, the medical imaging specialist posted net income of 10 million euros, compared with 1.3 million a year earlier, and an EBITDA margin adjusted for exceptional costs of 15.4%, compared with 12.7% in the first half of 2023.

Sales rose by 10.7% to 419.2 million euros. At constant exchange rates (CER), growth came out at 11.8%, a trajectory 'driven by all activities and geographical areas', with an acceleration in the second quarter.

Copyright (c) 2024 CercleFinance.com. All rights reserved.